Search alternatives:
11 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search)
9 11 » _ 11 (Expand Search)
11 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search)
9 11 » _ 11 (Expand Search)
-
281
-
282
-
283
-
284
The Immunophenotyping Changes of Peripheral CD4+ T Lymphocytes and Inflammatory Markers of Class III Obesity Subjects After Laparoscopic Gastric Sleeve Surgery - A Follow-Up Study
Published 2021“…A significant reduction of plasma IL-6, TNF-α, and MCP-1, but IL-10 significantly increased after LGS, with all <0.05. …”
Get full text
Get full text
-
285
A Facile Synthesis of Poly(aniline-co-3-trifluoromethyl aniline) Doped Silver Nanoparticles in Micellar Solution: Its Humidity Sensor Application
Published 2018“…The electrical conductivity of this nanocomposite changes from 1.86 × 10–9 to 2.86 × 10–11 S/cm due to the steric effect of trifluoromethyl group. …”
Get full text
Get full text
Get full text
-
286
Screening of Qatari Microalgae and Cyanobacteria for Application in CO2 Utilization
Published 2018“…., with a maximum biomass productivity of 157.7 ± 10.9 mg L-1 d-1 at 30˚C, with a decreasing productivity for increasing temperatures. …”
Get full text
Get full text
-
287
Mobile Epifauna Associated To Artificial Substrates In Offshore Qatari Waters
Published 2019“…After one year, two replicate plates per 5 m depth interval were retrieved and analyzed for each site. …”
Get full text
-
288
-
289
-
290
-
291
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analy...
Published 2024“…The most pronounced decline was in children younger than 5 years, with a 79·2% (72·4–84·6) decrease in diarrhoeal deaths. Global YLLs also decreased substantially, from 186 million (147–221) in 1990 to 51·4 million (39·9–65·9) in 2021. …”
Get full text
Get full text
Get full text
article -
292
-
293
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
Published 2023“…Results The number of patients initiated on rivaroxaban therapy significantly increased from 152 (3.3%) in 2015 to 1342 (28.9%) in 2020 (p <0.001). Within BMI categories, a similar increasing trend was observed in underweight, normal, and overweight patients, while from 2018 to 2020, there was a decreasing trend in rivaroxaban prescribing in all obese classes. …”
Get full text
Get full text
-
294
-
295
-
296
-
297
-
298
-
299
-
300